Review decisions

Showing 100 results of 283 total
Summary Safety Review - Proscar and Propecia (finasteride) - Assessing the potential risk of suicidal thoughts and/or behaviour (suicidal ideation)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00218
Issued / Original Publication Date: 2019-02-26
Summary Safety Review - Ferriprox (deferiprone) - Assessing the potential risk of brain and nervous system (neurological) disorders in children
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00217
Issued / Original Publication Date: 2019-02-25
Summary Safety Review - Opioid-containing cough and cold products - Assessing the potential risk of opioid use disorder and related harms in children and adolescents
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00216
Issued / Original Publication Date: 2019-02-18
Summary Safety Review - Hydrochlorothiazide - Assessing the potential risk of non-melanoma skin cancer
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00215
Issued / Original Publication Date: 2019-01-30
Summary Safety Review - Sulfamethoxazole containing products - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00214
Issued / Original Publication Date: 2019-01-07
Summary Safety Review - Vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR TKIs) - Assessing the potential risk of abnormal structural changes of the artery walls including rupture (Artery Dissections and Artery Aneurysms)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00213
Issued / Original Publication Date: 2018-12-03
Summary Safety Review - Sunscreen products - Assessing the potential risk of skin reactions
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00211
Issued / Original Publication Date: 2018-11-26
Updated Date: 2020-06-26
Summary Safety Review - JAKAVI (ruxolitinib) - Assessing the potential risk of drug interactions with P-glycoprotein (P-gp) substrates (including rosuvastatin)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00212
Issued / Original Publication Date: 2018-10-09
Summary Safety Review - Beta-lactam antibiotics - Assessing the potential risk of severe skin side effects
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00209
Issued / Original Publication Date: 2018-09-10
Summary Safety Review - Fibristal (5 mg ulipristal acetate) - Assessing the potential risk of rare but serious liver injury
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00210
Issued / Original Publication Date: 2018-09-07

Displaying 91 - 100 of 283 | Page 10 of 29
Report a problem or mistake on this page
Please select all that apply:
Date modified: